Recently added

Neoadjuvant Osimertinib for Resectable EGFR-Mutated Non–Small Cell Lung Cancer

He, Jianxing; Tsuboi, Masahiro; Weder, Walter; Chen, Keneng; Hochmair, Maximilian; Shih, Jin-Yuan; MARTINEZ-MARTI, ALEX (American Society of Clinical Oncology, 2025-09-10)

Long-term survival in patients with pancreatic cancer treated with second-line liposomal irinotecan plus 5-fluorouracil/leucovorin: observations from Korea, Italy, and Germany

Potthoff, Karin M.; Procaccio, Letizia; Yoo, Changhoon; Hédouin-Biville, Fabienne; Lonardi, Sara; Macarulla, Teresa (Elsevier, 2025-09)

Plain language summary of the EVOKE-01 study of sacituzumab govitecan vs docetaxel in patients with non-small cell lung cancer

Mountzios, Giannis; de Marinis, Filippo; Paz-Ares, Luis; Juan-Vidal, Oscar; FELIP, ENRIQUETA; Reinmuth, Niels (Taylor & Francis, 2025-10)

Safety of having a subsequent pregnancy after prior diagnosis of breast cancer during pregnancy in young BRCA carriers

Frank, Sophie; Paluch-Shimon, Shani; Perachino, Marta; Blondeaux, Eva; Bernstein Molho, Rinat; Carrasco Lopez, Estela; Balmaña, Judith; Saura Manich, Cristina; Delucchi, Virginia (Elsevier, 2025-08)

Insights on Oligometastatic Non-Small-Cell Lung Cancer

Mascaro-Baselga, Pau; Geng Cahuayme, Abraham André Arturo; Torresan, Sara; Yaringaño Cerna, Jesus Gustavo; Pardo Aranda, Nuria; Masfarre, Laura; MARTINEZ-MARTI, ALEX; Valdivia Bustamante, Augusto; Salva de Torres, Clara; Priano, Ilaria; Iranzo, Patricia; Mirallas, Oriol; cedres, susana; Rocha, Pedro; FELIP, ENRIQUETA (MDPI, 2025-08)

Scientia. Dipòsit d'Informació Digital del Departament de Salut

HVH - Articles científics: Recent submissions

Neoadjuvant Osimertinib for Resectable EGFR-Mutated Non–Small Cell Lung Cancer

Long-term survival in patients with pancreatic cancer treated with second-line liposomal irinotecan plus 5-fluorouracil/leucovorin: observations from Korea, Italy, and Germany

Plain language summary of the EVOKE-01 study of sacituzumab govitecan vs docetaxel in patients with non-small cell lung cancer

Safety of having a subsequent pregnancy after prior diagnosis of breast cancer during pregnancy in young BRCA carriers

Insights on Oligometastatic Non-Small-Cell Lung Cancer

Scientia. Dipòsit d'Informació Digital del Departament de Salut

HVH - Articles científics: Recent submissions

Neoadjuvant Osimertinib for Resectable EGFR-Mutated Non–Small Cell Lung Cancer ﻿

Long-term survival in patients with pancreatic cancer treated with second-line liposomal irinotecan plus 5-fluorouracil/leucovorin: observations from Korea, Italy, and Germany ﻿

Plain language summary of the EVOKE-01 study of sacituzumab govitecan vs docetaxel in patients with non-small cell lung cancer ﻿

Safety of having a subsequent pregnancy after prior diagnosis of breast cancer during pregnancy in young BRCA carriers ﻿

Insights on Oligometastatic Non-Small-Cell Lung Cancer ﻿

Neoadjuvant Osimertinib for Resectable EGFR-Mutated Non–Small Cell Lung Cancer

Long-term survival in patients with pancreatic cancer treated with second-line liposomal irinotecan plus 5-fluorouracil/leucovorin: observations from Korea, Italy, and Germany

Plain language summary of the EVOKE-01 study of sacituzumab govitecan vs docetaxel in patients with non-small cell lung cancer

Safety of having a subsequent pregnancy after prior diagnosis of breast cancer during pregnancy in young BRCA carriers

Insights on Oligometastatic Non-Small-Cell Lung Cancer